 Home > Medical News > Latest Medical News > What are the differences between the four new coronavirus vaccines that have been on the market?

What are the differences between the four new coronavirus vaccines that have been on the market?

 Last Update: 2021-03-17
 Source: Internet
 Author: User

Tags

what neulasta used

what cumin spice

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

What are the differences between the four new coronavirus vaccines that have been on the market in my country? The answer is here!

What are the differences between the four new coronavirus vaccines that have been on the market in my country? The answer is here! What are the differences between the four new coronavirus vaccines that have been on the market in my country? The answer is here!

China News Service, March 15th.

academician

Wang Junzhi said that these four new crown vaccines are actually two technical routes.

Wang Junzhi introduced that adenovirus vector vaccines, my country adopts type 5 adenovirus as a vector, introduces new coronavirus antigen genes, and prepares a live vector vaccine through a bioreactor.

Wang Junzhi pointed out that no matter what kind of technical route the new crown vaccine adopts, the most important thing is to combine the characteristics of the antigen itself and the characteristics of the pathogen itself, and use suitable technology to develop a safe, effective, and controllable quality vaccine.

Another reporter at the meeting asked questions about the progress in the development of other vaccines except for the four vaccines that have been approved for marketing.

Fellow Fellow

In response, Wang Junzhi said that currently 17 new crown vaccines in our country have entered the clinical stage, 4 of which have been conditionally approved, and the other three technical routes are basically in Phase III clinical or immediately enter Phase III clinical phase.

"Once enough data is obtained to prove that the effectiveness of the program design is met and the data is acceptable, the applicant can submit a marketing application to the State Food and Drug Administration, and the State Food and Drug Administration will organize it in the first time.

aspx?id=3570" style="color:#ba1413" target="_blank">Focus on the new crown pneumonia epidemic

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.